Literature DB >> 17612819

Illicit use of opioids: is OxyContin a "gateway drug"?

Lauretta E Grau1, Nabarun Dasgupta, Alison Phinney Harvey, Kevin Irwin, Anthony Givens, Mark L Kinzly, Robert Heimer.   

Abstract

This study examines whether individuals who engage in illicit, non-medical use of OxyContin are distinguishable from other non-medical users of opioids and whether OxyContin serves as a "gateway" to heroin and/or injection drug use. The study sample included active nonmedical users of opioids, who are 16 years or older and residents of Cumberland County, Maine. Possible associations between type of opioid used and behavioral and descriptive variables were assessed. The study sample was predominantly urban-dwelling, male, Caucasian, and economically disadvantaged. OxyContin users could only be distinguished from heroin users (cf non-heroin opioid users). Polyopioid use within the first year of initiation was associated with quicker progression to heroin and injection drug use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612819     DOI: 10.1080/10550490701375293

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  53 in total

1.  Understanding the etiology of prescription opioid abuse: implications for prevention and treatment.

Authors:  Khary K Rigg; John W Murphy
Journal:  Qual Health Res       Date:  2013-05-08

2.  Respondent-driven sampling to recruit young adult non-medical users of pharmaceutical opioids: problems and solutions.

Authors:  Raminta Daniulaityte; Russel Falck; Linna Li; Ramzi W Nahhas; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2011-08-31       Impact factor: 4.492

3.  Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.

Authors:  April M Young; Jennifer R Havens
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

Review 4.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

5.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

Review 6.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

7.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

8.  Prescription opioids prior to injection drug use: Comparisons and public health implications.

Authors:  Alia A Al-Tayyib; Stephen Koester; Paula Riggs
Journal:  Addict Behav       Date:  2016-08-19       Impact factor: 3.913

9.  HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.

Authors:  Christina S Meade; Leah J McDonald; Roger D Weiss
Journal:  Am J Addict       Date:  2009 Jul-Aug

10.  Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications.

Authors:  Martin Y Iguchi; Allison J Ober; Sandra H Berry; Terry Fain; Douglas D Heckathorn; Pamina M Gorbach; Robert Heimer; Andrei Kozlov; Lawrence J Ouellet; Steven Shoptaw; William A Zule
Journal:  J Urban Health       Date:  2009-05-27       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.